Related Experiment Video

Updated: Jul 16, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Reactivation of JC virus and development of PML in patients with multiple sclerosis

K Khalili1, M K White, F Lublin

  • 1Department of Neuroscience, Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA 19122, USA. kamel.khalili@temple.edu

Neurology
|March 29, 2007
PubMed

Insights

Progressive multifocal leukoencephalopathy (PML) emerged in multiple sclerosis (MS) patients treated with natalizumab and interferon beta-1A. This review examines JC virus (JCV) pathogenesis and its link to MS treatments.

Area of Science:

  • Neuroimmunology
  • Viral Pathogenesis

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare, serious brain infection.
  • JC virus (JCV) is the causative agent of PML.
  • PML occurrence in multiple sclerosis (MS) patients treated with natalizumab and interferon beta-1A has raised significant concerns.

Purpose of the Study:

  • To review the current understanding of JC virus (JCV) molecular biology, life cycle, and pathogenesis.
  • To explore the relationship between JCV infection and the clinical perspectives of MS.
  • To investigate the role of natalizumab's alpha4beta1-integrin inhibition in JCV reactivation and PML development.

Main Methods:

  • Literature review of JCV, PML, and MS.
  • Analysis of pathogenetic mechanisms linking JCV infection to PML.
  • Examination of the impact of natalizumab and interferon beta-1A on JCV reactivation.

Main Results:

  • PML has not been previously associated with MS or interferon beta treatment alone.
  • The combination therapy of natalizumab and interferon beta-1A was associated with PML development in MS patients.
  • Alpha4beta1-integrin inhibition by natalizumab is a key area of investigation for JCV re-expression.

Conclusions:

  • A deeper understanding of JCV infection steps leading to PML is crucial.
  • Further research is needed on natalizumab's role in JCV reactivation and spread.
  • The findings have implications for the future of immunomodulatory treatments for MS.

More Related Videos

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...